| PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism AA Ren, DA Snellings, YS Su, CC Hong, M Castro, AT Tang, MR Detter, ... Nature 594 (7862), 271-276, 2021 | 122 | 2021 |
| Novel murine models of cerebral cavernous malformations MR Detter, R Shenkar, CR Benavides, CA Neilson, T Moore, R Lightle, ... Angiogenesis 23, 651-666, 2020 | 38 | 2020 |
| Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models W Li, R Shenkar, MR Detter, T Moore, C Benavides, R Lightle, R Girard, ... The Journal of clinical investigation 131 (3), 2021 | 36 | 2021 |
| Developmental expression of the Sturge–Weber syndrome-associated genetic mutation in Gnaq: a formal test of Happle's paradominant inheritance hypothesis SE Wetzel-Strong, F Galeffi, C Benavides, M Patrucco, JL Bullock, ... Genetics 224 (4), iyad077, 2023 | 7 | 2023 |
| Propranolol as therapy for cerebral cavernous malformations: a cautionary note R Shenkar, T Moore, C Benavides, R Lightle, MR Detter, N Hobson, ... Journal of Translational Medicine 20 (1), 160, 2022 | 6 | 2022 |
| Novel hemorrhage models of cerebral cavernous malformations MR Detter, R Shenkar, CR Benavides, CA Neilson, T Moore, R Lightle, ... bioRxiv, 2020.02. 12.944421, 2020 | 4 | 2020 |
